VSM Wealth Advisory’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VSM Wealth Advisory's PFE Position: Q2 2026 in Review
VSM Wealth Advisory increased its Pfizer (PFE) stake by 0.04% in Q2 2026, buying an estimated $52 and bringing the position to 5,210 shares worth $125K. The position accounts for 0.03% of the portfolio, ranked #142.
VSM Wealth Advisory first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $148K in Q2 2025. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- VSM Wealth Advisory held 5,210 shares of Pfizer worth $125K as of Q2 2026.
- VSM Wealth Advisory bought 2 Pfizer shares in Q2 2026, an estimated $52.
- Pfizer made up 0.03% of VSM Wealth Advisory's portfolio in Q2 2026, its #142 holding.
- VSM Wealth Advisory first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
- VSM Wealth Advisory's Pfizer position peaked at $148K in Q2 2025.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on VSM Wealth Advisory's 13F filing for Q2 2026, filed 23 Jul 2026.